Pancreatic Cancer

This is a type of cancer that starts in the pancreas, a gland located behind your stomach. It's a serious illness, but treatments are available. It's often diagnosed later when symptoms appear, like unexplained weight loss or stomach pain.

Condition

What people with Pancreatic Cancer report

Every report comes from a Lived member, sent anonymously.

Have you tried Gemcitabine for Pancreatic Cancer?

NameHow it went

About Pancreatic Cancer

What It Is

Pancreatic cancer is cancer that starts in the pancreas, a gland deep in the abdomen behind the stomach. The pancreas has two jobs: it makes digestive juices that flow into the small intestine, and it makes hormones, including insulin, that control blood sugar. Most pancreatic cancers begin in the cells that make digestive juices, and about 90% are a type called pancreatic ductal adenocarcinoma. When people talk about pancreatic cancer, they usually mean this type. It is a serious cancer largely because it is hard to find early. It rarely causes symptoms at first, and the pancreas sits too deep for a doctor to feel a tumor during a routine exam. By the time symptoms such as yellowing skin, back pain or weight loss appear, the cancer has often spread. In the United States, about half of cases are diagnosed after the cancer has reached distant organs such as the liver or lungs. A much smaller group, pancreatic neuroendocrine tumors (also called islet cell tumors), grows from the hormone-making cells and makes up only about 1 to 2% of pancreatic tumors. These behave very differently, can be benign or cancerous, and generally have a better outlook. Some release excess hormones: insulinomas, for example, make too much insulin and are usually not cancer. The rest of this page focuses on the common type.

Causes & Risk Factors

Pancreatic cancer develops when changes in a cell's DNA let it grow and divide out of control. Most of these changes build up over a lifetime rather than being inherited, and in most people no single cause can be identified. Age is a major factor: nearly two thirds of people are 65 or older at diagnosis. Smoking is the most important risk factor people can change, and smokers are considerably more likely to develop the disease. Long-standing diabetes, chronic pancreatitis (lasting inflammation of the pancreas), obesity and heavy alcohol use, which can lead to pancreatitis, also raise risk. Up to 10% of pancreatic cancers are linked to inherited gene changes, such as BRCA1 and BRCA2 (better known for their link to breast and ovarian cancer) or those of Lynch syndrome. Having a parent, sibling or child with pancreatic cancer also increases risk. Screening with imaging is not recommended for people at average risk, but people with two or more close relatives with the disease, or a known inherited gene change, may be offered genetic counseling and regular screening. Having a risk factor does not mean someone will develop pancreatic cancer, and many people who are diagnosed have none. A new diagnosis of diabetes or a first bout of pancreatitis can occasionally be an early effect of a tumor rather than a cause, which is why doctors take notice when either appears without an obvious explanation.

How It's Diagnosed

Diagnosis usually begins with symptoms such as yellowing of the skin or eyes, pain in the upper abdomen that spreads to the back, or unexplained weight loss. A doctor asks about these and about family history, examines the abdomen and usually orders a CT scan, often using a protocol designed to show the pancreas in detail. MRI, including a version called MRCP that maps the bile and pancreatic ducts, and endoscopic ultrasound, in which a thin scope passed through the mouth brings an ultrasound probe right next to the pancreas, give closer views. A biopsy, a small sample of tissue examined under a microscope, confirms the diagnosis and is often taken with a needle during endoscopic ultrasound. Blood tests check liver function, since a tumor can block the bile duct, and measure CA 19-9, a substance many pancreatic cancers release. CA 19-9 is not raised in everyone with the disease, so a normal result does not rule it out; when it is raised, it helps doctors gauge how much cancer is present and how it responds to treatment. Imaging also determines the stage. Doctors use stages 1 to 4, but for planning treatment they focus on whether the tumor can be removed. Resectable means surgery can take it out completely. Borderline resectable means it touches a major blood vessel, so chemotherapy is often given first to make surgery possible. Locally advanced means it has grown into major vessels and usually cannot be removed, and metastatic means it has spread to other organs. Two further tests are recommended for everyone with pancreatic cancer. Molecular testing of the tumor looks for gene changes that specific targeted or immune treatments act on. Genetic testing of blood or saliva checks for an inherited gene change, which can shape treatment and tells relatives whether they should consider testing too.

Treatment Options

Treatment depends mostly on whether the cancer can be removed, along with a person's overall health and preferences. Most plans combine more than one approach. Surgery offers the best chance of long-term survival, but only for the minority of people whose cancer has not spread or grown into major blood vessels. A tumor in the head of the pancreas is removed with a Whipple procedure (pancreaticoduodenectomy), a major operation that also removes the gallbladder, part of the bile duct, part of the small intestine and part of the stomach. Tumors in the body or tail are removed with a distal pancreatectomy, which sometimes includes the spleen. Because the cancer often comes back even after a complete operation, chemotherapy is given before surgery, after it, or both. Radiation is sometimes added, though whether it improves survival is still uncertain. Chemotherapy is the main treatment when the cancer has spread or cannot be removed. The two most common combinations are FOLFIRINOX (four drugs: leucovorin, fluorouracil, irinotecan and oxaliplatin) and gemcitabine with nab-paclitaxel (Abraxane). The aim is to slow the cancer, extend life and ease symptoms rather than cure it. These regimens can be demanding, with fatigue, nausea, nerve damage in the hands and feet and a higher risk of infection, so the choice depends partly on how much treatment someone can tolerate. Tumor and genetic testing opens other options for some people. Olaparib (Lynparza), a targeted pill, can be used as maintenance treatment for metastatic cancer in people with an inherited BRCA gene change whose cancer has not grown during first-line platinum-based chemotherapy, such as the oxaliplatin in FOLFIRINOX. A newer FDA-approved option, daraxonrasib (Rasonque), is a pill that blocks RAS proteins, which are switched on by KRAS gene changes in about 9 of 10 pancreatic cancers. It is approved for adults whose cancer has spread to other organs, either after earlier treatment or when combination chemotherapy is not an option. It extended survival and improved quality of life, but can cause difficult rash and mouth sores. A small number of cancers with specific DNA repair defects respond to immunotherapy such as pembrolizumab. Because current treatments have real limits, experts encourage people at every stage to consider a clinical trial. Palliative care, which focuses on comfort and quality of life, is part of treatment from the start, not only near the end of life. A stent placed through an endoscope can reopen a bile duct blocked by the tumor and relieve jaundice, or keep food moving out of the stomach. Nerve block injections and radiation can ease pain when medicine is not enough, and pancreatic enzyme replacement therapy, capsules taken with meals, helps the body digest food when the pancreas no longer makes enough enzymes.

What to Expect

The outlook depends heavily on the stage at diagnosis. Overall, about 13 in 100 people are alive five years after diagnosis. That figure is about 44 in 100 when the cancer is still confined to the pancreas, 17 in 100 when it has reached nearby tissue or lymph nodes, and about 3 in 100 when it has spread to distant organs. These numbers come from people diagnosed several years ago, so they do not reflect the newest treatments, and they cannot predict what will happen to any one person. Overall health, how completely a tumor is removed and how the cancer responds to treatment all matter. For people who have surgery, the operation is major and recovery takes time. Many need enzyme capsules with meals for the long term, and some develop diabetes because insulin-making tissue has been removed. Regular scans and blood tests afterward watch for the cancer returning, which is common and most often happens elsewhere in the body. For people with advanced cancer, treatment is often ongoing and adjusted to how well it works and how it feels. Eating can become one of the hardest parts: the cancer itself can cause weight and muscle loss (cachexia), and treatment can blunt appetite and disrupt digestion. Help from a dietitian, enzyme replacement and early attention to pain make a real difference to daily life. Many people and their families also live with anxiety and uncertainty, and counseling, support groups and caregiver support are part of good care. Talking early about goals and preferences helps keep treatment aligned with what matters most.

When to Seek Help

See a doctor soon about yellowing of the skin or the whites of the eyes, especially with dark urine, pale stools or itching. Ongoing pain in the upper abdomen that spreads to the back, unexplained weight loss or loss of appetite, and newly diagnosed diabetes without the usual risk factors are also worth an evaluation. People with two or more close relatives with pancreatic cancer, or a known inherited gene change, can ask about genetic counseling and screening. During treatment, call the care team right away for a fever of 100.5°F (38°C) or higher or chills, since infections during chemotherapy can become life threatening. Also call promptly about a swollen, painful leg, which can signal a blood clot, a risk that is higher with pancreatic cancer, and about new or returning jaundice or vomiting that stops you keeping food down, which can mean the tumor is blocking the flow of bile or food. Sudden shortness of breath or chest pain needs emergency care (call 911), because it can mean a blood clot has traveled to the lungs.

Questions to Ask Your Doctor

  1. 1.Can this cancer be removed with surgery, and if not now, could treatment make that possible later?
  2. 2.What did molecular testing of the tumor and genetic testing show, and do the results open any targeted treatments or clinical trials?
  3. 3.What is the goal of the treatment you recommend, and how will we know whether it is working?
  4. 4.How can we manage pain, weight loss and digestion, and when should a palliative care team join my care?
  5. 5.Should my relatives consider genetic counseling or screening?

Last reviewed • Oct 2026

Educational content, not medical advice.